Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SPESOLIMAB-SBZO for Pustular psoriasis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 70 adverse event reports in the FDA FAERS database where SPESOLIMAB-SBZO was used for Pustular psoriasis.

Most Reported Side Effects for SPESOLIMAB-SBZO

Side Effect Reports % Deaths Hosp.
Generalised pustular psoriasis 29 14.7% 1 3
Drug ineffective 20 10.1% 0 1
Rash 14 7.1% 0 1
Pruritus 13 6.6% 0 1
Fatigue 11 5.6% 0 0
Psoriasis 10 5.1% 0 2
Pustule 9 4.6% 0 0
Headache 7 3.5% 0 0
Urinary tract infection 7 3.5% 1 4
Arthralgia 6 3.0% 0 1
Condition aggravated 6 3.0% 0 0
Intentional product use issue 6 3.0% 0 0
Maternal exposure during pregnancy 6 3.0% 0 0
Off label use 6 3.0% 0 2
Peripheral swelling 6 3.0% 0 1

Other Indications for SPESOLIMAB-SBZO

Generalised pustular psoriasis (80) Product used for unknown indication (36) Psoriasis (7)

Other Drugs Used for Pustular psoriasis

APREMILAST (349) SECUKINUMAB (317) ADALIMUMAB (207) METHOTREXATE (159) CYCLOSPORINE (157) ETANERCEPT (146) INFLIXIMAB (144) ACITRETIN (129) USTEKINUMAB (120) EFALIZUMAB (101)

Related Pages

SPESOLIMAB-SBZO Full Profile All Pustular psoriasis Drugs SPESOLIMAB-SBZO Demographics SPESOLIMAB-SBZO Timeline